{"url":"https://lda.senate.gov/api/v1/filings/4b3fed05-dbce-42ef-b9ea-5976be2cbc29/","filing_uuid":"4b3fed05-dbce-42ef-b9ea-5976be2cbc29","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2010,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/4b3fed05-dbce-42ef-b9ea-5976be2cbc29/print/","filing_document_content_type":"text/html","income":"180000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"James B. Christian, Partner","dt_posted":"2011-01-20T15:43:06.163000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2550 M STREET, NW","registrant_address_2":null,"registrant_different_address":null,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20037","registrant":{"id":30906,"url":"https://lda.senate.gov/api/v1/registrants/30906/","house_registrant_id":31917,"name":"SQUIRE PATTON BOGGS","description":"Law Firm","address_1":"2550 M STREET, NW","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20037","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GLENN WILLARD","contact_telephone":"+1 202-457-6000","dt_updated":"2026-07-10T16:40:57.961456-04:00"},"client":{"id":137453,"url":"https://lda.senate.gov/api/v1/clients/137453/","client_id":1007250,"name":"RANBAXY INC.","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":false,"state":"NJ","state_display":"New Jersey","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-03-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.369/HR 1706, Preserve Acess to Affordable Generics; HR 759, FDA Globalization Act; S.3690, Drug Safety & Accountability Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S.3677, the Financial Services & General Government Appropriations Act; HR3082, Continuing Appropriations & Surface Transportation Act.","foreign_entity_issues":"Ranbaxy Labs Limited; interests are same as registrant.","lobbyists":[{"lobbyist":{"id":3753,"prefix":null,"prefix_display":null,"first_name":"ANURAG","nickname":null,"middle_name":null,"last_name":"VARMA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":27512,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"JONAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1141,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"TODD","last_name":"TUTEN","suffix":null,"suffix_display":null},"covered_position":"RepMichaelBilirakis91-92;93-95;98-01","new":false},{"lobbyist":{"id":38816,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":null,"last_name":"RASMUSSEN","suffix":null,"suffix_display":null},"covered_position":"SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"S.369/HR 1706, Preserve Acess to Affordable Generics; HR 759, FDA Globalization Act; S.3690, Drug Safety & Accountability Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care; Implementation of P.L. 111-152, Health Care & Education Reconciliation; S.3677, the Financial Services & General Government Appropriations Act; HR3082, Continuing Appropriations & Surface Transportation Act.","foreign_entity_issues":"Ranbaxy Labs Limited - Interests are same as Registrant.","lobbyists":[{"lobbyist":{"id":3753,"prefix":null,"prefix_display":null,"first_name":"ANURAG","nickname":null,"middle_name":null,"last_name":"VARMA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":1141,"prefix":"mr","prefix_display":"MR.","first_name":"MATTHEW","nickname":null,"middle_name":"TODD","last_name":"TUTEN","suffix":null,"suffix_display":null},"covered_position":"RepMichaelBilirakis91-92;93-95;98-01","new":false},{"lobbyist":{"id":27512,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"JONAS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":38816,"prefix":null,"prefix_display":null,"first_name":"ERIC","nickname":null,"middle_name":null,"last_name":"RASMUSSEN","suffix":null,"suffix_display":null},"covered_position":"SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}